ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0060487;lung epithelial cell differentiation;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;45.96109296208386;6.781341354126479;0.0015382764191427488;0.6370391240755715;[YAP1, GRHL2, HOXA5]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, HOXA11, HOXA10, PDGFRB, LHCGR, TGFB2, BIK, INHBA, EIF2S2, KITLG, SFRP2, NASP, MSH2, KIT]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[YAP1, GATA3, MYB]
GO:0035162;embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;36.11381869205153;6.832634648514029;0.0012086970112962418;0.6725415662651573;[FLT3LG, GATA3, KITLG, KIT]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, THBS1, CLDN4, TLR2]
GO:0008064;regulation of actin polymerization or depolymerization;9.0;0.6729672293956388;0.7327242398781084;9.05316010758856;119.88573797499163;4.556717802602145;0.004012467759863614;0.6292713855144111;[CYFIP1, PYCARD, EPS8, ARFIP1, PFN1, CORO1A, SPTA1, NCKAP1L, VASP, CXCL12, JMY, LMOD1, CCR7, SPTAN1, CIT, HCK, EPS8L1, GSN]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, FMR1, ARAP1, CCR7]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, GAB1, TTC7B, VAV1, BTC, LCK, KIT, HBEGF, CD19, FYN, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0097490;sympathetic neuron projection extension;5.0;1.0;0.7902410118609202;9.628524252492122;51.99108915072818;8.390779266560578;0.0017400949649324319;0.7193458537639684;[NRP1, NRP2]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[ABHD12, CHL1, SLITRK6, DRD4, SCN1A, NR4A2, CXCL12]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, PTGS2]
GO:0007413;axonal fasciculation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;31.514364772604104;6.7325511899570465;0.0010547574278521217;0.6952223462072524;[NRP1, CNR1, NCAM2, EPHA3]
GO:2000119;negative regulation of sodium-dependent phosphate transport;9.0;1.0;0.896240625180289;9.628524252492122;90.50243821892585;9.777073627680469;0.0030290351602810317;0.896240625180289;[SFRP4]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, DPP4, EGR1, TGFB2, TGFB1, CAV1, NR4A2, CXCL12, NOX4, CD24, ALAD, MYOCD, ADSL, KCND2, AGTRAP, SIRT1, TGFBR3, IL1B, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, TEK]
GO:0048368;lateral mesoderm development;5.0;1.0;0.7902410118609202;9.628524252492122;34.03910770959907;8.390779266560578;0.0011392583018322185;0.7193458537639684;[YAP1]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, TNR, DCC, SIRT1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, BCL6, SIPA1]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, STMN1, EPHB1, DCC, PAX2, MAP1B, DSCAML1, SLITRK6, LINGO1, GP5, PTK2, NR4A2, LRFN4, OGN]
GO:0032288;myelin assembly;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;32.851297377660025;7.292166977892469;0.0010995033589821146;0.6631627702307852;[PMP22, TLR2]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ITGB3, HMGB2, TNFAIP3, LAMC1, CDH3, AKT1, GHSR, ARG1, SIRT1, PAX2, MMP12, AGTR1, C5AR1, TGFA, IQGAP3, CCL5, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0031114;regulation of microtubule depolymerization;9.0;0.8259837884571596;0.8092325194088689;9.420884887713877;74.89162891543653;6.444869117505266;0.0025065554217094913;0.7258315315665724;[CKAP2, MAP1B]
GO:0021828;gonadotrophin-releasing hormone neuronal migration to the hypothalamus;11.0;1.0;0.9324289523296623;9.628524252492122;88.9737192139704;9.083926447120524;0.002977870310942956;0.8969813732811862;[NRP1]
GO:0036486;ventral trunk neural crest cell migration;8.0;1.0;0.875;9.628524252492122;24.653414450138296;8.67846133901236;8.251275950136018E-4;0.8188169164668168;[NRP1]
GO:0055062;phosphate ion homeostasis;8.0;0.9326813400603323;0.8413406700301662;9.541512875502493;105.4863272505807;7.292166977892469;0.0035305324415458874;0.747921758369865;[SFRP4]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, COL1A1, HLA-DRB1, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, KCNA5, HLA-DMA, HLA-DMB, DMD, CENPK, CENPL, GOPC, KCNG2, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, MIF, TGFA, PTK2, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, MIS12, CCT8, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, H1FX, CAV2, CAV1, HMGA1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, EGF, TTC19, TEK, CDA, BIN2, NUP205, ACMSD, NCKAP1L, SERPINA1, BRD2, GSN, GTF2H1, TNF, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, NACC2, LSM3, HOPX, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, PLN, WASF3, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, NDUFA11, KNTC1, CHRNB4, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, AXIN2, DNM2, TGFBR3, COLEC12, HIST1H2BK, HSPD1, REPS2, RBMX]
GO:0061162;establishment of monopolar cell polarity;4.0;0.7980440201809971;0.6490220100904985;9.040737587590003;22.64548009891681;6.832634648514029;7.579238393018128E-4;0.5994212536750128;[MAP1B]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, NTF3, STAP1, TEK]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[SFRP4, SYK, EGF, FMR1, NTF3, SELE]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, SPINT2, ANTXR1, CDH5, C1GALT1C1, CDH3, CDH1, MEF2C, ACTN1, COL23A1, CLDN3, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ST14, TGFB2, BCL11B, BCL6, ID1, NOX4, NRP1, COL14A1, ITGB3, LAMC1, GP1BA, PALLD, COL6A3, YAP1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:1903375;facioacoustic ganglion development;6.0;1.0;0.8231203125901445;9.628524252492122;32.51846529594618;9.083926447120524;0.0010883637687365787;0.7876727335416686;[NRP1]
GO:1902287;semaphorin-plexin signaling pathway involved in axon guidance;8.0;1.0;0.875;9.628524252492122;28.581916314885376;7.292166977892469;9.566110170045473E-4;0.747921758369865;[NRP1, PLXND1]
GO:0046622;positive regulation of organ growth;6.0;0.811012628672052;0.7286266269261705;9.360260265897443;146.55654105553208;5.926926025970411;0.004905115536804883;0.6262235851885184;[YAP1, MEF2C, MAPK14, TGFBR3, BASP1, AKT1]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, NR4A3, PDGFD, PDGFC]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[CHRM2, GABRB1, CHRM1, GRIK3, GRM5, CHRNB4, KCND2, NPY1R, SLC5A7, SLC1A3, SLC1A6, GJC1, SV2A, HRH4, KCNMB3, SLC17A6, GABRE, DRD4, EGR3, HTR1E, GABRA5, PCDHB15, PCDHB14, PCDHB10, P2RX1, PNOC, PCDHB16, PLP1, PMP22, PCDHB4, PCDHB8, GPR19]
GO:0045773;positive regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1257.908905926367;6.113511981550823;0.04210107903683872;0.7450742393735527;[CYFIP1, NRP1, PAK1, CXCL12, MAP1B]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[DOCK5, NRP1, OLFM4, DNM2, FLNA]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, SFN, BARD1, LYN, PLK2, CDKN1A, CHAF1B, CHAF1A, CTLA4, SIRT1, UNG, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, COPS5, BCL6, CNOT3, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, PPP1R15A, RBBP8, POLR2E, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, SOX4, ESCO2, MIF, EPHA2, POLA1, BRCA2, RAD51C, SGK1, YAP1, PCNA, RAD54B, RPA1, MLH1, RPA3, DCLRE1A, PSMD14, HMGA1, JMY, TOPBP1, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[CYFIP1, PID1, EDNRB, AKT1, PRKACB, PTGDR, MEF2C, SFRP4, CLDN4, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, PRKAR2B, LYN, EGR1, EGR2, JUN, CDC6, COL1A1, SDC1, EZH2, ROBO2, CDKN1A, GABRB1, BRCA2, CTSS, CTSH, TIMP3, CCR7, TIMP1, CTSB, ANXA1, DUSP1, ANXA3, ARG1, TACR3, AVPR1A, FOS, SIRT1, CEACAM1, IL1B, KIT, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, GNAI1, PAK1, CCL19, SORT1, SORBS1, RAMP1, TNC, TNF, CTGF, RUVBL2, MEN1, PDGFRB, GHSR, LHCGR, ADAM9, FOXO1, IGFBP7, CYC1, GAS2L1, EIF2B3, TGFB2, TGFB1, CAV1, DHCR24, INHBA, NFKB1, NR4A2, NR4A1, GH1, IL6, CXCL12, NR4A3, NASP, ALPL, HMGB2, GHR, ALAD, HHEX, UQCRFS1, GLP2R, TGFBR3, RETN, THBS1, P2RY6, PLN, RBBP8, FYN, CSK, TSHR, CD4, TEK]
GO:0021782;glial cell development;4.0;0.7586651285174919;0.629332564258746;8.781226392104918;32.15320660831846;5.8650506222523235;0.001076138889173156;0.5499389615747303;[DLL1, TSPAN2, WASF3, SOX4, LYN, EIF2B3, TGFB1, GSN, PLP1, CD9, S100A8, TLR2]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL20, CXCL13, PYCARD, CXCL10, CXCL12, CCL5, XCL1, CCR2]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[YAP1, EGR1, CDKN1A, NOX4]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, ITGB3, NCF4, VAV1, NCKAP1L, FYN, MAPK14, PTK2]
GO:0051894;positive regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;280.4986055833795;6.599019797332524;0.009388035896519984;0.712474179321389;[NRP1, EPB41L5, TEK]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[NRP1, ARHGEF10L, CTGF, PAK1, TPM1, NOX4]
GO:0050847;progesterone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;7.697632086000634;0.0018077141342769656;0.7686572628545723;[YAP1]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[LOXL2, TMEM100, EPB41L5, TGFB2, TGFB1, TGFBR3, ENG]
GO:0050966;detection of mechanical stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;71.50580126066325;7.379178354882098;0.0023932348171512878;0.7004918368257019;[CXCL12, FYN, SCN1A]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, PCNA, C5AR1, ATIC, TGFB1, ANXA3, SULF2, TGFBR3, NFKBIA, CXCL12, NR4A3, EZH2]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[CALCA, CXCL12, EPHB1]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, GAB1, VAV1, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[JUN, CHL1, TNC, JAM3]
GO:2000761;positive regulation of N-terminal peptidyl-lysine acetylation;11.0;1.0;0.9324289523296623;9.628524252492122;926.293767378532;9.777073627680469;0.031002218783891387;0.9324289523296623;[SOX4]
GO:0060385;axonogenesis involved in innervation;9.0;1.0;0.896240625180289;9.628524252492122;65.99544162831262;8.16763571524637;0.0022088080392582156;0.8139338954918922;[NRP1]
GO:1902174;positive regulation of keratinocyte apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.67846133901236;0.00434501821119318;0.8400575416471059;[SFRP4, GSN]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[CD151, LAMB3, ITGB4, LAMA3, LAMC2, LAMC1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, EPHB1, SOX4, MEF2C, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, HGS, CD274, CUL5, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, IL6, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, XCL1, PDE5A, DLL1, THBS1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, ITGB3, FASLG, CYR61, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, CTHRC1, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, BTC, SFRP2, TGFA, PKHD1, EGR1, EGR3, TNFSF12, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, CAV2, NR4A1, IL6, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, ZAP70, IFNG, NDUFS4, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:1902336;positive regulation of retinal ganglion cell axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;1458.3969986044274;9.083926447120524;0.04881123507120434;0.9126727335416687;[NRP1]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[PHB2, AKT1, PROK2, MEF2C, CLDN7, PRKCQ, ABCB4, GATA3, SLC30A10, FIGNL1, SFN, NCKAP1L, BARD1, JUN, PLK2, AZU1, CDKN1A, CHL1, TIMP1, GPR37, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, GPNMB, NTF3, FLNA, CCL19, GABRA5, PF4, TNF, CTGF, CLEC5A, F2R, MSH2, BLM, CORO1A, FOXO1, PSAP, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, CX3CR1, LRP1, NLRC4, CCL5, CCL2, FYN, TIE1, DNAJA3, IL2RB, SLC46A2, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, SOX4, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, CTSH, CCR7, CCR5, FCER1G, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, CXCR2, PDPN, LILRB1, CD40LG, GRINA, COMP, ARHGDIA, PDGFRB, GHSR, C5AR1, PSEN2, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, HSPD1, TEK]
GO:0150020;basal dendrite arborization;10.0;1.0;0.9152410118609203;9.628524252492122;197.41096074002914;8.67846133901236;0.006607167197638665;0.8590579283277371;[NRP1]
GO:1902455;negative regulation of stem cell population maintenance;5.0;0.8436909121759173;0.712086467948879;9.427853557029971;80.47091400422747;7.8311634786251565;0.002693289072600737;0.6907270763441554;[PAX2, LOXL2]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[COX6A1, LOXL2, COX6B1, POR, COX7A2L, UQCRC1, NDUFB10, UQCRB, UQCRH, CYC1, UQCRQ, P4HA2, NOX4, COX7B, ETFA, COX7C, UQCRFS1, COX8A, NDUFC2, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NDUFB7, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, UQCR10, COX5B, COX5A, NDUFA8, NDUFA7, NDUFA6, NDUFA4, NDUFA3, NDUFA2, COX6C, NDUFAB1]
GO:0045785;positive regulation of cell adhesion;4.0;0.5768751454443798;0.53843757272219;7.230628979693751;21.972203539282862;3.842179432060882;7.353898787604294E-4;0.44648923483520947;[TFRC, MYB, AKT1, TNFSF11, ICOSLG, SFRP2, COL8A1, PRKCQ, HHLA2, GATA3, EPB41L5, KLRK1, NCKAP1L, ICOS, ELANE, LYN, EGR3, JUP, TNFSF14, AZU1, VNN1, CD28, CD24, NRP1, CD3E, CTLA4, CCR7, CD36, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, VAV1, CEACAM6, IL1B, PTAFR, PAK1, HLA-DMB, PDPN, FLNA, CCL19, IL12RB1, LILRB1, LILRB2, CD40LG, HLA-DPB1, CD86, CD83, CD80, SIRPG, CXCL13, TNF, PYCARD, GRAP2, IL6R, TPM1, OLFM4, ADAM9, CARD11, CD274, BLM, CORO1A, DPP4, BTLA, NLRP3, TGFB2, TGFB1, CAV1, IL6, CXCL12, PTPRC, NR4A3, BCL6, DOCK5, SIRPB1, CYR61, TNFSF13B, DUSP10, EMILIN2, EMILIN1, DNM2, ZAP70, IFNG, LCK, XCL1, HSPD1, CCL5, CCL2, FYN, CSK, CD4, CD6, DNAJA3, PTPN6, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, CEBPE, ABLIM3, E2F5, E2F7, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, MAPK14, MEIS2, MEIS1, RBMX]
GO:0060301;positive regulation of cytokine activity;8.0;1.0;0.875;9.628524252492122;129.14918693253554;9.777073627680469;0.004322507059909803;0.875;[NRP1]
GO:1902459;positive regulation of stem cell population maintenance;5.0;0.8436909121759173;0.712086467948879;9.427853557029971;80.27467007535621;7.697632086000634;0.0026867209649094857;0.6838982747154925;[YAP1, LBH]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, FYN, JUN, WFS1, GABRA5, NR4A2, NR4A3]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, CTGF, ADAMTS1, ITGB6, FCER1G, SYK, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, PTK2, ZYX, PLP1, LAT]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGB3, LAMB1, LAMC1, ANTXR1, TEK]
GO:0032387;negative regulation of intracellular transport;6.0;0.6144040707577935;0.6303223479690412;8.112176763124033;60.463658338724606;5.618190544320798;0.0020236642308374482;0.610434838299289;[LRRK2, FMR1, PLN, CD36, IL13RA2, BARD1, MDFIC, MAP1B, PKIG]
GO:0032024;positive regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1037.3763533530775;5.514393750639154;0.03472005296862251;0.6972473647141411;[BLK, SOX4, CFTR]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, IFNG, BANK1, KIT, HBEGF, TGFA, CCL5, NTF3, STAP1, FYN, LYN, TGFB1, ACE, EGF, GH1, CD4, IL6, CSPG4, CD24]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[NRP1, CD3E, MAP1B]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[LAMC1, MMP8, MMP9, CTSS, MMP12, CTSG, TIMP1, ELANE]
GO:0021522;spinal cord motor neuron differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;49.74132219478667;6.781341354126479;0.0016647972895758778;0.6699184248047958;[SOX4]
GO:0090280;positive regulation of calcium ion import;9.0;0.8653626801206646;0.8289219652406215;9.420884887713877;92.69484377077161;6.8867018697843045;0.0031024130010644134;0.7484268790654467;[PDGFRB, LGALS3, CXCL12, CCL2]
GO:0097475;motor neuron migration;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;22.707504301080803;7.8311634786251565;7.599997335300838E-4;0.7236063770733796;[NRP1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, TNC, PHB2, PAX2, COL1A1, MYB, HOXA2, EPHA3]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, LILRB1, CCR7, CCL19]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[CYFIP1, NRP1, SEMA5B, NRP2, ALCAM, MAP1B, VCL]
GO:0035767;endothelial cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;58.99646552848538;7.474488534686424;0.0019745586078665435;0.7572456912631272;[NR4A1, NRP1, EGR3, CXCL13]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[NRP1, HMGB2, TNFAIP3, FASLG, TNF, LGALS3, AKT1, SFRP2, IL1B, CX3CR1, YAP1, THBS1, FYN, TNFRSF10B, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ITGB3, HMGB2, AKT1, PLCG1, GHSR, JUN, EGR3, ARG1, CAV2, TNFSF12, SIRT1, NR4A1, LRG1, CXCL12, AGTR1, TEK]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, AKT1, MAPK14]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, COL11A1, COL12A1, LOXL2, COL1A1, SFRP2]
GO:0030510;regulation of BMP signaling pathway;11.0;0.7508913569872202;0.8078746308232723;9.360260265897443;322.7842812572362;5.334422371190153;0.010803299406686577;0.705231560468336;[LRP2, PCSK6, CYR61, SFRP4, SFRP2, ENG]
GO:1905050;positive regulation of metallopeptidase activity;10.0;0.8933024483968273;0.861892236059334;9.59573442966913;498.63588947967594;7.8311634786251565;0.016688894477719096;0.8157270763441555;[MAPK14, ANTXR1]
GO:0033622;integrin activation;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;7.57984905034425;0.0013529121422039536;0.6778748447945537;[CXCL12, TLN1]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[TAF9, MIF, SIRT1, CXCL12, SFRP2]
GO:0060563;neuroepithelial cell differentiation;6.0;0.7671156992804218;0.7066781622303554;8.801845679307654;25.58801435984686;6.686031174322154;8.564078129062366E-4;0.665044257777226;[JAG1, SOX4]
GO:0045606;positive regulation of epidermal cell differentiation;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;258.7690385433134;6.641579411751319;0.008660766843029667;0.6905700452391912;[SFRP4, SFN]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, THBS1, CCL5, IL6, LIN28A, CD28, EIF3E, EIF3D]
GO:0060449;bud elongation involved in lung branching;6.0;1.0;0.8231203125901445;9.628524252492122;21.218694376440094;7.8311634786251565;7.101706051943016E-4;0.7236063770733796;[YAP1]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[PTGS2, FRZB, PRDM16, AKT1, TMEM64, MAPK14, KLF5, SFRP2]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, MEIS2, MEIS1, KLF5, POU2AF1, RBMX]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[NR4A1, NRP1, EGR3]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, CXCL13, LOXL2, DPP4, EGR3, TNFSF12, PTK2, NR4A1, ID1, S100P]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, CTGF, NRBP1, RUNX2, MAZ, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, MED23, YAP1, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, GTF2H1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL20, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ACAP1, PRTN3, ARHGAP15, ADAP2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, LRRK2, TAGAP, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, CXADR, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, PF4]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[NRP1, SEMA5B, LRRK2, CTSZ, ARHGAP4, ARHGDIA, TNR, DCC, PAQR3, RGMA, NLGN1, LRP1, LINGO1, PLK2, SEMA4B, PTK2, ID1, PMP22, ITM2C]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[SOX4, MEN1, PAX2, LIN28A, IL1B, NOX4]
GO:0070367;negative regulation of hepatocyte differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;233.43799561860925;9.777073627680469;0.00781295963279838;0.8509193652572005;[FRZB]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[TNFAIP3, AKT1, FBXO5, SOX4, FYN, CAV1]
GO:0072307;regulation of metanephric nephron tubule epithelial cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;122.78518948428719;7.8311634786251565;0.004109509792542791;0.7754860644832351;[YAP1, PAX2]
GO:0032489;regulation of Cdc42 protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;50.14528765113853;7.8311634786251565;0.0016783176498546674;0.8157270763441555;[ABCA1, NRP1]
GO:0150018;basal dendrite development;7.0;1.0;0.8509193652572005;9.628524252492122;34.02047363004817;9.777073627680469;0.0011386346359592329;0.8509193652572005;[NRP1]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, F2R, NPY1R, DGKZ, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0014033;neural crest cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;46.51447820026907;7.9853141584524145;0.001556797725050427;0.6986103492792611;[MEF2C, FRZB]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, CCL1, FPR2, S100A14, PLA2G7, CCR2]
GO:2000051;negative regulation of non-canonical Wnt signaling pathway;8.0;0.7671156992804218;0.7585578496402109;9.203641058526856;236.5222601423257;8.16763571524637;0.007916187190749309;0.7926932703116032;[SFRP4, SFRP2]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, LGR4, NAIP]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[NRP1, SEMA5B, SEMA4B]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[TNFAIP3, PHB2, PYCARD, HAVCR2, MEN1, CHUK, IRAK3, SIRT1, SFRP4, XCL1, SIK1, PKHD1, FLNA, NLRP3, WFS1, NFKBIA, NLRP12, ID1, CCDC22, EZH2]
GO:0003143;embryonic heart tube morphogenesis;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;47.28828305781204;5.618190544320798;0.0015826962772532312;0.610434838299289;[YAP1, DLL1, MEF2C, ENG]
GO:0048842;positive regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2927.4139206492227;7.8311634786251565;0.09797790942264722;0.8486063770733797;[NRP1, CXCL12]
GO:0006930;substrate-dependent cell migration, cell extension;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[NRP1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, CALCRL, FPR2, ADRB2, IGLV1-44, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ASGR1, ASGR2, CD36, FCER1G, SYK, DNM2, CEACAM1, COLEC12, LRP1, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, CTGF, EDNRB, AKT1, PRKACB, MEN1, GHSR, LHCGR, POR, ADCY9, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, HHEX, TIMP1, ANXA1, ARG1, GLP2R, SIRT1, TGFBR3, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0048846;axon extension involved in axon guidance;6.0;1.0;0.8231203125901445;9.628524252492122;104.6753254820163;7.697632086000634;0.003503388942206243;0.7167775754447168;[NRP1, NRP2, ALCAM]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, PTPN22, CD3E, CD3D, CCR9, CCR6, SOX4, ANXA1, FCER1G, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, KIT, BLM, GATA3, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, BMX, CD4, PTPRC, DNAJA3, CD28, GPR18, IL18R1]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, ST14, JAG1, ANXA1, ADAM9, EPHA2]
GO:0030857;negative regulation of epithelial cell differentiation;6.0;0.6634067003016617;0.6548236627409754;8.638125548464245;143.89713366415532;6.139487467954083;0.004816107564726769;0.6370939872166814;[YAP1, JAG1, CAV1, DLL1, GRHL2, IFNG, FRZB, ID1, S1PR3, HOXA7, EZH2]
GO:0002328;pro-B cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;23.263450360134797;8.390779266560578;7.786067478076512E-4;0.7522251544931926;[SOX4]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, JUN, JAG1, JUP, AZU1, COL1A1, FOS, SIRT1, MMP12, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, PKP3, BLM, FOXO1, NFKB1, CXCL10, MYD88, CIITA, HHEX, PPP1R12A, PPP1R15A, CCL5, E2F5, E2F7, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, BRCA2, CD3E, CD3D, CTSH, CD36, RGMA, IL1B, KIT, YAP1, IL17A, CD86, CD80, ACTG2, CCNE1, CAV1, HMGA1, INHBA, IL6, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, ACTA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, NFE2, FZD5, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, FMR1, TNC, TNF, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, SMARCD3, CEBPE, ABLIM3, POLR2E, POLR2K, POLR2L, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, NHLH2, BCL11B, IFNA2, PRL, RHOG, MDFIC, TLR6, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, MEIS2, MEIS1, RBMX]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, BTC, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CCL23, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0033603;positive regulation of dopamine secretion;9.0;1.0;0.896240625180289;9.628524252492122;382.96729536294987;7.9853141584524145;0.01281757072760856;0.8046099625986299;[CXCL12]
GO:0050767;regulation of neurogenesis;6.0;0.47270034079162526;0.5594704829859571;7.335989495351577;60.464536800347794;3.1570004211501135;0.002023693632157412;0.4845694609432947;[CYFIP1, CPNE5, EDNRB, MYB, AKT1, HOXA2, MEF2C, PAQR3, SFRP2, SPINT1, MAP1B, HOXB3, EPHA3, SDC2, GATA3, FLRT2, LYN, JAG1, BCL11B, PLK2, PTK2, ID1, EZH2, ITM2C, ROBO2, NRP1, CTSZ, ARHGAP4, CCR2, RGMA, IL1B, KIT, TLR2, YAP1, CXCR4, PAK1, NTF3, FLNA, SCARB2, SEMA5B, PLXND1, FMR1, ARHGDIA, TNR, STAP1, TGFB1, SYT2, CXCL12, LIN28A, BCL6, TCF4, LRRK2, HMGB2, DUSP10, DCC, DNM2, CX3CR1, NLGN1, SMARCD3, LRP1, LRP2, DLL1, RAB21, CNR1, FYN, S1PR5, LINGO1, SEMA4B, MEIS1, PMP22]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, BARD1, HACE1, SIRT1, FBXW2, CUL5, MARCH3, MARCH1, NLRC4, RNF24, SKP2, NAIP, PDZRN3, PCNA, KLHL14, UBE2M, TNFAIP3, HIST1H2BK]
GO:0061551;trigeminal ganglion development;6.0;1.0;0.8231203125901445;9.628524252492122;32.51846529594618;8.390779266560578;0.0010883637687365787;0.7522251544931926;[NRP1]
GO:0060982;coronary artery morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.54494596988572;7.57984905034425;0.0010892500530622757;0.710754145523778;[NRP1, LRP2]
GO:0061037;negative regulation of cartilage development;6.0;0.8259837884571596;0.7361122068187242;9.36615998802463;85.27219906913868;6.558197802812269;0.002853983762847292;0.6585068532133508;[EFEMP1, FRZB, ADAMTS12]
GO:1901166;neural crest cell migration involved in autonomic nervous system development;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;23.960267269578353;8.390779266560578;8.01928582672223E-4;0.7800242071602487;[NRP1]
GO:0048339;paraxial mesoderm development;5.0;1.0;0.7902410118609202;9.628524252492122;34.03910770959907;7.697632086000634;0.0011392583018322185;0.6838982747154925;[YAP1, EPB41L5, NUP133]
GO:1901202;negative regulation of extracellular matrix assembly;7.0;1.0;0.8509193652572005;9.628524252492122;97.16264097367828;9.777073627680469;0.0032519461526892665;0.8509193652572005;[ANTXR1]
GO:0022029;telencephalon cell migration;6.0;0.6873818243518346;0.6668112247660618;8.68406264365127;21.32120993996455;6.250713103064308;7.136017088474478E-4;0.6427820713687392;[CX3CR1, NRP1, LRRK2, CXCL12, TNR]
GO:1902378;VEGF-activated neuropilin signaling pathway involved in axon guidance;10.0;1.0;0.9152410118609203;9.628524252492122;58.60337150540505;9.777073627680469;0.0019614021046756975;0.9152410118609203;[NRP1]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[YAP1, GJC1, TMEM100, HHEX, MYOCD, TGFB1, CAV1, TIE1, PTK2, TGFBR3, ENG]
GO:0060627;regulation of vesicle-mediated transport;5.0;0.4849414530207067;0.5327117383712736;6.805163204878917;26.124861613659725;3.5745381104925467;8.743756073601922E-4;0.47304305706453076;[LGALS3, SLC11A1, ACTN4, SFRP4, EPHA3, CFTR, LLGL2, STXBP2, NCKAP1L, LYN, AZU1, SDC1, NRP1, RAC2, CD36, CCR2, ANXA1, FCER1G, SYK, RAB33B, HCK, CEACAM1, IL1B, TLR2, PTAFR, GNAI2, NTF3, CCL19, NR1H2, LILRB1, GOPC, FMR1, SIRPG, TNF, PYCARD, IL13RA2, CD177, MAP2K2, TSC2, HGS, PRTN3, CD151, CORO1A, STAP1, EVI5, TGFB1, SYT2, CAV1, SELE, TBCK, MCTP1, ITGAM, LRRK2, SIRPB1, TBC1D9, DNM2, FGR, IFNG, NLGN1, LRP1, DLL1, RAB21, CCL2, CSK, EGF, VPS41, PTX3, FCGR2B]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, TNF, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, GATA3, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, CHUK, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:1903507;negative regulation of nucleic acid-templated transcription;9.0;0.5547065974044363;0.6735939238825073;8.375761283996754;898.5514994986271;2.646975117554892;0.030073710044371104;0.5316070557889775;[EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, BTAF1, FLNA, NR1H2, LGR4, GMNN, TNF, DACH1, RUVBL2, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, XCL1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, SOX4, RUNX2, SFRP2, PCBP3, EGR1, BCL11A, ID1, IFNA2, PTPRK, XPO1, CD36, MDFIC, IL1B, YAP1, ARID4A, LOXL2, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, CAV1, HMGA1, NR4A2, NR4A3, MXD1, CREBZF, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, MEIS2]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[SKP2, ESCO2, SPARCL1, SDC2, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, FBXW2, PSMD14, CUL5, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, LAMC1, CYR61, LAMB1]
GO:1904835;dorsal root ganglion morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;28.42528359967652;9.777073627680469;9.513686609867987E-4;0.7902410118609202;[NRP1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX4, PCBP3, EGR1, BCL11A, ID1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, CAV1, NR4A2, NR4A3, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1I1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, IL1B, EZH2, ENG]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, PCNA, SFN, E2F7, SOX4, PLK2, CNOT3]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, PLXND1, SFRP2, COL4A1, ENG]
GO:0047497;mitochondrion transport along microtubule;8.0;0.811012628672052;0.780506314336026;9.446202695698167;156.37963208010012;6.832634648514029;0.005233885553189209;0.7244212536750128;[UXT, MAP1B]
GO:2000737;negative regulation of stem cell differentiation;6.0;0.7586651285174919;0.7024528768488905;9.136047767394327;115.31702415177813;6.781341354126479;0.0038595570197761534;0.6699184248047958;[YAP1, JAG1, LBH]
GO:0018057;peptidyl-lysine oxidation;9.0;1.0;0.896240625180289;9.628524252492122;320.93714865322556;8.16763571524637;0.010741477540741758;0.8139338954918922;[LOXL2]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, GATA3, CDH3, FRZB, SOX4, FZD5, EGF, TMEM64, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, LGR4]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, P2RY6, PAK1, NR4A3, CCL5, PDGFD, NOX4]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, ANTXR1, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT]
GO:0050930;induction of positive chemotaxis;8.0;1.0;0.875;9.628524252492122;129.39753142075796;7.138016298065211;0.004330818926435078;0.7400384854347593;[CXCL12, NTF3, AZU1]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA3]
GO:0032060;bleb assembly;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[PMP22, EMP1, MYLK]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPIB, MEF2A, MEF2C, PADI4, ATF3, GATA3, JUN, HACE1, EZH2, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, NFKB1, CIITA, FASLG, HHEX, E2F5, E2F7, POU2AF1, CCNH, UXT, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, LOXL2, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, ELF3, CREB5, TAF9, MAPK14, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, GTF2H1, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, LBH, RFC1, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX4, EBF1, NHLH2, BCL11B, BCL11A, MDFIC, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, C5AR1, NLRP3, CBX4, NR4A2, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0061549;sympathetic ganglion development;5.0;1.0;0.7902410118609202;9.628524252492122;31.419853007278505;7.57984905034425;0.0010515942041217404;0.6778748447945537;[NRP1, NRP2]
GO:1903237;negative regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;459.0491676986248;8.390779266560578;0.015363962525443897;0.8443458537639685;[CXCL12]
GO:1902946;protein localization to early endosome;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;33.466755985853425;8.67846133901236;0.001120102204721561;0.7947362817240173;[NRP1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, ATP1B1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, CD24, GPR18, CXCL9, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[RUVBL2, TLE4, AXIN2, AES, SFRP4, SFRP2, PFDN5, FOXO1, FRZB, CTHRC1, EGR1, CAV1, TMEM64, MAPK14]
GO:0003357;noradrenergic neuron differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;23.8388145050385;8.16763571524637;7.978636679434658E-4;0.7079342821725234;[SOX4]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[NAV1, PSRC1, MAP1B]
GO:0035729;cellular response to hepatocyte growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;78.10713999468214;7.138016298065211;0.00261417568375975;0.6881587980249038;[NRP1]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL20, PPBP, CXCL10, CXCL11, CXCL12, XCL1, PF4]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, F2R, MIF, EPHA3, EPHA2, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, TIE1, CD4, TEK]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, HOXA5, MEF2C, ATF3, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, LCK, NLRC4, CCL5, CCL2, P2RX1, MNDA, PPP2R1A, SOX4, SFRP4, SFRP2, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, CTSZ, CTSH, VAV1, IL1B, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, PDGFRB, NLRP3, TGFB2, TGFB1, CAV1, INHBA, EIF2S1, IL6, NR4A3, JMY, UBE2M, MMP9, DNM2, IFNG, BCL2A1, THBS1, HSPD1, CNR1, HSPE1, LTBR]
GO:0033148;positive regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;233.77170011230152;7.379178354882098;0.007824128421887714;0.7523715242355574;[, YAP1, PAK1, SKP2]
GO:0010721;negative regulation of cell development;6.0;0.5334320500414464;0.5898363376108677;7.526609854960228;116.92646206421391;4.053488525728088;0.003913423458305296;0.5304159043023727;[SEMA5B, EDNRB, ARHGDIA, TNR, HOXA2, PAQR3, ACTN4, TACSTD2, STAP1, TGFB1, JAG1, PLK2, PTK2, LIN28A, ID1, ITM2C, NRP1, LRRK2, CTSZ, ARHGAP4, DUSP10, DCC, RGMA, IL1B, LTF, NLGN1, LRP1, DLL1, PAK1, FRZB, S1PR3, LINGO1, SEMA4B, LILRB1, MEIS1, PMP22]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[YAP1]
GO:0032332;positive regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;229.711107350086;6.832634648514029;0.007688224036432589;0.7003406189322132;[POR, RUNX2, HOXA11, LOXL2]
GO:0035567;non-canonical Wnt signaling pathway;8.0;0.6997970393407541;0.724898519670377;8.606873004960141;31.415129658942366;5.299736813202263;0.0010514361179036673;0.6460287870901297;[CELSR1, FRZB, AP2M1, CTHRC1, FZD5, VANGL1, SFRP4, SFRP2, PFN1]
